Please Wait.....
Report
Advance Directives Market By Component (Software, Services) , By Demographics (Elderly Population (65 yrs & above) , Middle Aged (40-60 yrs) , Young Adults (18-39 yrs)) By End User (Payers, Providers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 231 Pages I Allied Market Research
The advance directives market was valued at $121.7 billion in 2023, and is projected to reach $510.2 billion by 2033, growing at a CAGR of 15.4% from 2024 to 2033.
Advance directives are legal documents that allow individuals to outline their preferences for medical care in the event that they become unable to communicate or make decisions for themselves due to a serious illness or injury. These documents are vital tools for planning future healthcare needs, ensuring that a person's wishes are respected and adhered to during times when they may be unable to voice their decision. They provide a clear and legally binding way for individuals to express their medical care preferences, thus assisting healthcare professionals with appropriate guidance on how to proceed with treatment and aligning medical interventions with the patient's values and desires.
Rise in awareness of the need for planning end-of-life care and medical decision-making acts as the key driving force of the global advance directives market. Governments of many countries have taken initiatives to raise awareness about the importance of advance directives and encourage individuals to document their medical care preferences. For instance, National Healthcare Decision Day initiated by the U.S. Government is held on April 16 each year. This initiative emphasizes on educating healthcare providers and consumers about advance care planning and make informed decisions about care and services before a crisis. However, lack of awareness regarding advance directives acts as a key deterrent factor of the global market. According to a study published by the National Center for Biotechnology Information-the world's largest database of freely accessible biomedical and genomic information-merely 5% to 25% individuals hold advance directives, although this might increase with age and hospitalization. On the contrary, increase in geriatric population is expected to offer remunerative opportunities for the growth of the market. As the population ages, there is an increased awareness of the need for planning end-of-life care and medical decision-making. In addition, advancements in technology such as developing user-friendly digital platforms and mobile apps for creating and storing advance directives can make the process more accessible and convenient.
The advance directives market is segmented into component, demographic, end user, and region. On the basis of component, the market is bifurcated into software and services. By demographic, it is divided into elderly population (65 years & above), middle aged (40-60 years), and young adults (18-39 years) . Depending on end user, it is classified into payers, providers, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By component, the services segment acquired significant market share in 2023.
On the basis of demographic, the elderly population segment led the advance directives market in 2023.
Depending on end user, the healthcare providers segment held a prominent position in market in 2023.
Region wise, North America is poised to dominate the market 2033.
Competition Analysis
Competitive analysis and profiles of the major players in the global advance directives market include West Health , MyDirectives, Inc., Aledade, VyncaCare, WiserCare, Sharp HealthCare, Vital Decisions LLC, Affirm Health, thanacare, and Honor My Decisions LLC. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Component
- Software
- Services
By Demographics
- Elderly Population (65 yrs above)
- Middle Aged (40-60 yrs)
- Young Adults (18-39 yrs)
By End User
- Payers
- Providers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- West Health
- MyDirectives, Inc.
- Aledade
- VyncaCare
- WiserCare
- Sharp HealthCare
- Vital Decisions LLC
- Affirm Health
- thanacare
- Honor My Decisions LLC
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: AEROSOL SPRAY STERILISER MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Desktop
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Portable
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: AEROSOL SPRAY STERILISER MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Healthcare Facilities
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Educational Institutions
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: AEROSOL SPRAY STERILISER MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Aerosol Spray Sterilizer Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Aerosol Spray Sterilizer Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Aerosol Spray Sterilizer Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Aerosol Spray Sterilizer Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Aerosol Spray Sterilizer Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Aerosol Spray Sterilizer Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Aerosol Spray Sterilizer Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Aerosol Spray Sterilizer Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Aerosol Spray Sterilizer Market
6.3.10.1. Market Size and Forecast, By Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Aerosol Spray Sterilizer Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Aerosol Spray Sterilizer Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Aerosol Spray Sterilizer Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. Australia Aerosol Spray Sterilizer Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Aerosol Spray Sterilizer Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Aerosol Spray Sterilizer Market
6.4.10.1. Market Size and Forecast, By Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Aerosol Spray Sterilizer Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Aerosol Spray Sterilizer Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Aerosol Spray Sterilizer Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Aerosol Spray Sterilizer Market
6.5.8.1. Market Size and Forecast, By Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Graco Inc.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Haier Inc.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Ebele Cosmeceuticals
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. The Clorox Company
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Ecolab
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Reckitt Benckiser Group Plc
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. AquaB Nanobubble Innovations Ltd
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. S.C. Johnson And Son Inc.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. The Claire Manufacturing Company
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. 3M
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 2. ADVANCE DIRECTIVES MARKET FOR SOFTWARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ADVANCE DIRECTIVES MARKET FOR SERVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 5. ADVANCE DIRECTIVES MARKET FOR ELDERLY POPULATION (65 YRS ABOVE), BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ADVANCE DIRECTIVES MARKET FOR MIDDLE AGED (40-60 YRS), BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. ADVANCE DIRECTIVES MARKET FOR YOUNG ADULTS (18-39 YRS), BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. GLOBAL ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 9. ADVANCE DIRECTIVES MARKET FOR PAYERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. ADVANCE DIRECTIVES MARKET FOR PROVIDERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. ADVANCE DIRECTIVES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. ADVANCE DIRECTIVES MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA ADVANCE DIRECTIVES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. U.S. ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 18. U.S. ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 19. U.S. ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. CANADA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 21. CANADA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 22. CANADA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. MEXICO ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. EUROPE ADVANCE DIRECTIVES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. GERMANY ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 31. GERMANY ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 32. GERMANY ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. FRANCE ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 34. FRANCE ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 35. FRANCE ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. UK ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 37. UK ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 38. UK ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. ITALY ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 40. ITALY ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 41. ITALY ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. SPAIN ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 43. SPAIN ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 44. SPAIN ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. REST OF EUROPE ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. ASIA-PACIFIC ADVANCE DIRECTIVES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. JAPAN ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 53. JAPAN ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 54. JAPAN ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. CHINA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 56. CHINA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 57. CHINA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. INDIA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 59. INDIA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 60. INDIA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. AUSTRALIA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 62. AUSTRALIA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 63. AUSTRALIA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 64. SOUTH KOREA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 65. SOUTH KOREA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 66. SOUTH KOREA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 67. REST OF ASIA-PACIFIC ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. LAMEA ADVANCE DIRECTIVES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. BRAZIL ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 77. SAUDI ARABIA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 78. SAUDI ARABIA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 79. SAUDI ARABIA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 80. SOUTH AFRICA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 81. SOUTH AFRICA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 82. SOUTH AFRICA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 83. REST OF LAMEA ADVANCE DIRECTIVES MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS, 2024 - 2033 ($BILLION)
TABLE 85. REST OF LAMEA ADVANCE DIRECTIVES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 86. WEST HEALTH: KEY EXECUTIVES
TABLE 87. WEST HEALTH: COMPANY SNAPSHOT
TABLE 88. WEST HEALTH: OPERATING SEGMENTS
TABLE 89. WEST HEALTH: PRODUCT PORTFOLIO
TABLE 90. WEST HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91. MYDIRECTIVES, INC.: KEY EXECUTIVES
TABLE 92. MYDIRECTIVES, INC.: COMPANY SNAPSHOT
TABLE 93. MYDIRECTIVES, INC.: OPERATING SEGMENTS
TABLE 94. MYDIRECTIVES, INC.: PRODUCT PORTFOLIO
TABLE 95. MYDIRECTIVES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. ALEDADE: KEY EXECUTIVES
TABLE 97. ALEDADE: COMPANY SNAPSHOT
TABLE 98. ALEDADE: OPERATING SEGMENTS
TABLE 99. ALEDADE: PRODUCT PORTFOLIO
TABLE 100. ALEDADE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. VYNCACARE: KEY EXECUTIVES
TABLE 102. VYNCACARE: COMPANY SNAPSHOT
TABLE 103. VYNCACARE: OPERATING SEGMENTS
TABLE 104. VYNCACARE: PRODUCT PORTFOLIO
TABLE 105. VYNCACARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. WISERCARE: KEY EXECUTIVES
TABLE 107. WISERCARE: COMPANY SNAPSHOT
TABLE 108. WISERCARE: OPERATING SEGMENTS
TABLE 109. WISERCARE: PRODUCT PORTFOLIO
TABLE 110. WISERCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111. SHARP HEALTHCARE: KEY EXECUTIVES
TABLE 112. SHARP HEALTHCARE: COMPANY SNAPSHOT
TABLE 113. SHARP HEALTHCARE: OPERATING SEGMENTS
TABLE 114. SHARP HEALTHCARE: PRODUCT PORTFOLIO
TABLE 115. SHARP HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 116. VITAL DECISIONS LLC: KEY EXECUTIVES
TABLE 117. VITAL DECISIONS LLC: COMPANY SNAPSHOT
TABLE 118. VITAL DECISIONS LLC: OPERATING SEGMENTS
TABLE 119. VITAL DECISIONS LLC: PRODUCT PORTFOLIO
TABLE 120. VITAL DECISIONS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121. AFFIRM HEALTH: KEY EXECUTIVES
TABLE 122. AFFIRM HEALTH: COMPANY SNAPSHOT
TABLE 123. AFFIRM HEALTH: OPERATING SEGMENTS
TABLE 124. AFFIRM HEALTH: PRODUCT PORTFOLIO
TABLE 125. AFFIRM HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126. THANACARE: KEY EXECUTIVES
TABLE 127. THANACARE: COMPANY SNAPSHOT
TABLE 128. THANACARE: OPERATING SEGMENTS
TABLE 129. THANACARE: PRODUCT PORTFOLIO
TABLE 130. THANACARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 131. HONOR MY DECISIONS LLC: KEY EXECUTIVES
TABLE 132. HONOR MY DECISIONS LLC: COMPANY SNAPSHOT
TABLE 133. HONOR MY DECISIONS LLC: OPERATING SEGMENTS
TABLE 134. HONOR MY DECISIONS LLC: PRODUCT PORTFOLIO
TABLE 135. HONOR MY DECISIONS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ADVANCE DIRECTIVES MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ADVANCE DIRECTIVES MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ADVANCE DIRECTIVES MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALADVANCE DIRECTIVES MARKET
FIGURE 10. GLOBAL ADVANCE DIRECTIVES MARKET SEGMENTATION, BY COMPONENT
FIGURE 11. ADVANCE DIRECTIVES MARKET FOR SOFTWARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ADVANCE DIRECTIVES MARKET FOR SERVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL ADVANCE DIRECTIVES MARKET SEGMENTATION, BY DEMOGRAPHICS
FIGURE 14. ADVANCE DIRECTIVES MARKET FOR ELDERLY POPULATION (65 YRS ABOVE), BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ADVANCE DIRECTIVES MARKET FOR MIDDLE AGED (40-60 YRS), BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. ADVANCE DIRECTIVES MARKET FOR YOUNG ADULTS (18-39 YRS), BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. GLOBAL ADVANCE DIRECTIVES MARKET SEGMENTATION, BY END USER
FIGURE 18. ADVANCE DIRECTIVES MARKET FOR PAYERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. ADVANCE DIRECTIVES MARKET FOR PROVIDERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. ADVANCE DIRECTIVES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: ADVANCE DIRECTIVES MARKET
FIGURE 27. TOP PLAYER POSITIONING, 2023
FIGURE 28. WEST HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. WEST HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. WEST HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. MYDIRECTIVES, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. MYDIRECTIVES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. MYDIRECTIVES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. ALEDADE: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. ALEDADE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. ALEDADE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. VYNCACARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. VYNCACARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. VYNCACARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. WISERCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. WISERCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. WISERCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. SHARP HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. SHARP HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. SHARP HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. VITAL DECISIONS LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. VITAL DECISIONS LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. VITAL DECISIONS LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. AFFIRM HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. AFFIRM HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. AFFIRM HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. THANACARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. THANACARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. THANACARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. HONOR MY DECISIONS LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. HONOR MY DECISIONS LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. HONOR MY DECISIONS LLC: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security